This federal contract award, with an identification number of SPE2DB22D3011|SPE2DB25FP8EC, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,264.39 firm fixed-price delivery order is for the supply of 4,566,769,778 units of Candesartan Cilexetil 16 mg tablets in 90-count packages. The contract has a completion date of December 20, 2024 and was awarded on December 19, 2024. This award is a part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 3/23/25, 12:56 AM